Oruka Therapeutics (ORKA) EPS (Basic) (QoQ) (2010 - 2024)
Oruka Therapeutics (ORKA) EPS (Basic) (QoQ) (2010 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Oruka Therapeutics | 6.98 Bn | 5.25 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -157.82% |
| Mar 31, 2024 | -524.91% |
| Dec 31, 2023 | 36.82% |
| Sep 30, 2023 | -15.67% |
| Jun 30, 2023 | -10.59% |
| Mar 31, 2023 | -17.46% |
| Dec 31, 2022 | 50.98% |
| Sep 30, 2022 | 34.46% |
| Jun 30, 2022 | -10.66% |
| Mar 31, 2022 | 43.87% |
| Dec 31, 2021 | -24.84% |
| Sep 30, 2021 | 2.52% |
| Jun 30, 2021 | -0.93% |
| Mar 31, 2021 | 70.15% |
| Dec 31, 2020 | -237.98% |
| Sep 30, 2020 | 54.62% |
| Jun 30, 2020 | 12.35% |
| Mar 31, 2020 | 10.76% |
| Dec 31, 2019 | -22.11% |
| Sep 30, 2019 | 33.12% |